Please send abstracts directly to galeotti@iaslc-lalca2008.com.
On-line submissions disabled.

Submission of the abstract should be done in two-page format. The 1st. page is the Submission Form, which should include the follow items:

1. Abstract Title, with the first letter of each major word of the title capitalized.

2. Authors names, listed by the first name, middle initial, and last name (e.g. Able B. Care, Barbara C. Doolittle, and David Ford).  No titles or degrees should be included.

3. Authors’ institutional affiliation. Capitalize each major word.  For those abstracts that represent collaborative efforts, list the department/division, school, and/or other organizational affiliation in the order that corresponds with the order of the authors.

4. Corresponding author information: name, address, telephone number, fax number, and e-mail address of the Corresponding Author.

5. Presentation type preferred. Assignment of the final form is at the discretion of the Abstract Program Committee.

6. Tumor Type and Related Conditions (select from list below). Final categorization is at the discretion of the Abstract Program Committee.

7. Topic Category (select from list below). Final categorization is at the discretion of the Abstract Program Committee.

8. A written statement as follows: “The corresponding author declares that this submitted abstract does not contain any copyright violation in its material nor is using in posters any table or drawings by third parts without their written authorization.”

9. A written statement as follows: “The corresponding author declares that information provided in the present abstract is complete and accurate for all of the authors, being submitted with the knowledge and consent of all the listed co-authors.”

The 2nd page is the Abstract Form, which should follow the guidelines below:

1. Abstracts should be prepared using 12 point Times New Roman font in single-line spacing.

2. The body of the abstract (not including title, authors and institutional affiliation) should not exceed 350 words.

3. The abstract is required to follow a coherent structural sequence:  Aim; Background; Material and Methods; Results; Discussion, Conclusions; Bibliographic References). However, text does not need to be divided in sections, and not all sections may be pertinent.

4. Acknowledgement to grants may be inserted before bibliographic references.

5. A minimum of four and maximum of six key words must accompany the abstract.

6. Drugs must be cited solely by their generic names and no brand names are acceptable.

7. Up to three tables can be included provided they are sent on separate files, along with the respective legends.

8. Illustrations are not acceptable on the abstracts.

 
 

Sponsorship